SDIC Fund Leads $72M Series B Round In Ascentage Pharma
December 26, 2016 — 20:27 CST
This Data Is Locked!
This area is available only to Subscribers.
A fund under China’s SDIC Fund Management Co. has led a RMB500 million (US$72 million) series B funding round in Ascentage Pharma, a Jiangsu province-based... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals